Incyte Corporation
INCY Healthcare Biotechnology
Incyte Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 21.2% from fiscal 2024. In the quarter to June 2026, revenue grew 37.7%, EPS grew 39.7%, free cash flow grew 1,829.5% and total debt fell 10.5%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years.
Follow INCY
Incyte Corporation (INCY) Operating cash flow
Incyte Corporation's operating cash flow for fiscal 2025 was $1.4B, up 321.5% from $335.3M in fiscal 2024. Over the twelve months to 30 June 2026 it was $2.0B. Over the past ten years it has ranged from −$124.6M (fiscal 2020) to $1.4B (fiscal 2025) — the current reading is the highest in ten years. Incyte Corporation ranks 4th of 628 Biotechnology companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $1.4B | 321.52% |
| FY2024 | $335.3M | (32.46%) |
| FY2023 | $496.5M | (48.81%) |
| FY2022 | $969.9M | 29.41% |
| FY2021 | $749.5M | — |
| FY2020 | −$124.6M | — |
| FY2019 | $710.7M | 111.36% |
| FY2018 | $336.2M | — |
| FY2017 | −$93.0M | — |
| FY2016 | $304.8M | 240.86% |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Jun 2026 | $507.7M | 37.45% |
| Mar 2026 | $369.4M | (32.02%) |
| Dec 2025 | $543.3M | (2.88%) |
| Sep 2025 | $559.4M | 1,150.28% |
| 42 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| RPRX Royalty Pharma PLC compare | $3.0B |
| INCY Incyte Corporation | $2.0B |
| EXEL Exelixis, Inc. compare | $1.2B |
| ALNY Alnylam Pharmaceuticals, Inc. compare | $911.8M |
| GMAB Genmab A/S Sponsored ADR compare | $891.0M |
| BNTX BioNTech SE Sponsored ADR compare | $758.6M |
| ASND Ascendis Pharma A/S compare | $404.1M |
| INSM Insmed, Inc. compare | −$778.9M |
| ROIV Roivant Sciences Ltd. compare | −$816.5M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on INCY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement